Search

everythinglearnresearchcommunity

for

Search:↓

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Ovarian vein sampling can effectively locate ovarian tumors when imaging is unclear.

A 17-year-old girl was diagnosed with a rare ovarian tumor, emphasizing the need for fertility preservation and psychosocial care.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

An ovarian tumor can cause high male hormones in postmenopausal women.

Female pattern hair loss is common in women with polycystic ovarian syndrome.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

PCOS may be influenced by factors in the blood, not just the ovaries.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Ovarian hemangioma is a rare, benign tumor that can be treated effectively with surgical removal.

PCOS is a major cause of infertility in women of childbearing age.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.